Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Outcome of Palliative Management of Malignant Large Bowel Obstruction w/Colorectal Stents or Surgery

ABSTRACT: The purpose of this study is to assess quality of life and bowel symptoms after treatment.The main objective is to compare the effect on quality of life of minimally invasive bowel surgery and endoscopic stent placement in the treatment of malignant large bowel obstruction.

DISEASE(S): Large Bowel Obstruction,Intestinal Obstruction

PROVIDER: 2015060 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

ACCESS DATA

Json Xml

Similar Datasets

Endoscopic Placement of Metal Stent in Patients With Cancer-Related Bowel Obstruction

Project description:RATIONALE: The use of endoscopy to place a metal stent in the large intestine is less invasive than surgery for treating cancer-related bowel obstruction and may have fewer side effects and improve recovery. PURPOSE: Phase I/II trial to study the effectiveness of endoscopic placement of a metal stent in treating patients who have cancer-related bowel obstruction.

| 2004056 | ecrin-mdr-crc

The CReST2 Trial: Are uncovered or covered stents more effective in relieving bowel obstruction in people with colorectal cancer

Project description:See https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-study-looking-at-different-types-of-stent-to-treat-bowel-obstruction-in-people-with-bowel-cancer

| 2419603 | ecrin-mdr-crc

Trial of colonic stenting for large bowel obstruction

Project description:Interventions: This study will compare the outcomes of colorectal surgery (bowel resection and possible stoma formation) versus colonic stent insertion using Ultraflex or Wallfex Precision Colonic Stent manufactured by Boston Scientific (TGA approved in Australia) to determine optimal management of non-curable colorectal cancer. Comparisons will be made between quality of life, length of stay, complications and cost to identify which group has the optimal outcome. The study will be conducted over 3 years. Primary outcome(s): To compare quality of life between surgical intervention and colonic stent insertion in the first 12 months following the procedure.[Daily until discharge from hospital, then at 1, 2, and 4 weeks and 3, 6 and 12 months] Study Design: Purpose: Treatment; Allocation: Randomised controlled trial; Masking: Open (masking not used);Assignment: Factorial;Type of endpoint: Efficacy

| 2452794 | ecrin-mdr-crc

Long-term Outcomes of Colonic Stent as a "Bridge to Surgery" for Malignant Large-bowel Obstruction

Project description:Study of long-term outcomes of colonic stent as a "bridge to surgery" for malignant large-bowel obstruction.

| 2317928 | ecrin-mdr-crc

Randomized Trial of Colonic Stents as a Bridge to Surgery

Project description:The objective of this randomized controlled trial was to evaluate the role colonic self-expanding metal stent (SEMS) placement as a bridge to surgery in patients with acute malignant left-sided colonic obstruction. The study was designed to test the hypothesis that SEMS placement could be effectively and safely used in this group of patients to relieve colonic obstruction thereby allowing safe recovery and medical stabilization before proceeding to elective surgery

| 2061470 | ecrin-mdr-crc

Enteral Stents for Colonic Obstruction

Project description:The purpose of this study is to verify whether stent positioning for malignant obstruction of the colon and rectum followed by elective surgery allows reduction of postoperative complications and hospital stay without worsening of evolution of the neoplastic illness, compared to emergency surgery. Primary endpoint will be 60 days postoperative morbidity. Others endpoints will be postoperative mortality, length of hospital stay, need for analgesia.

| 2048876 | ecrin-mdr-crc

Randomized controlled trial of stent placement in patients with inoperable malignant colorectal obstruction (JIVROSG-0806)

Project description:Interventions: Stent placement in the region of colonic stenosis. Other treatments except surgical intervention. Primary outcome(s): Improvement of the symptoms from colorectal obstruction. Study Design: Parallel Randomized

| 2619030 | ecrin-mdr-crc

Endoscopic Placement of Metal Stents in Treating Patients With Cancer- Related Duodenal Obstruction

Project description:RATIONALE: The use of endoscopy to place metal stents in the duodenum is less invasive than surgery for treating cancer-related duodenal obstruction and may have fewer side effects and improve recovery. PURPOSE: Phase I/II trial to study the effectiveness of endoscopic placement of metal stents in treating patients who have cancer-related obstruction of the duodenum.

| 2004055 | ecrin-mdr-crc

S1316, Surgery or Non-Surgical Management in Treating Patients With Intra-Abdominal Cancer and Bowel Obstruction

Project description:This partially randomized clinical trial studies surgery or non-surgical management in treating patients with intra-abdominal cancer and bowel obstruction. Bowel obstruction is a common problem for advanced cancer patients and can negatively affect quality of life. It is not yet known whether surgery or non-surgical management is the best treatment option for bowel obstruction and can lead to better quality of life.

| 2176709 | ecrin-mdr-crc

Gene expression response to implanted drug (paclitaxel)-eluting or bare metal stents in denuded human LIMA arteries

Project description:[original title] Gene expression response to the implantation of drug (paclitaxel)-eluting or bare metal stents in denuded human LIMA arteries. Different clinical outcomes have been observed for paclitaxel-eluting and bare metal cardiovascular stents. The aim of this project was to identify genes that might be associated with the observed clinical outcomes. Human left internal mammary artery (LIMA) was divided into three segments and and two of the segments were fitted with either a paclitaxel-eluting stent or a bare metal stent. The experiment includes three groups: control, paclitaxel-eluting stent, and bare metal stent, respectively. Each group includes four biological replicates (patients 1, 2, 4 and 5).

2010-03-07 | E-GEOD-19136 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data